Extrapyramidal syndrome with sodium valproate.
作者信息
Lautin A, Stanley M, Angrist B, Gershon S
出版信息
Br Med J. 1979 Oct 27;2(6197):1035-6. doi: 10.1136/bmj.2.6197.1035-a.
Abstract
摘要
相似文献
1
Extrapyramidal syndrome with sodium valproate.
Br Med J. 1979 Oct 27;2(6197):1035-6. doi: 10.1136/bmj.2.6197.1035-a.
2
[Iatrogenic dementia and extrapyramidal syndrome: rare adverse effect of valproic acid-aspirin combination].
Presse Med. 2010 Feb;39(2):279-80. doi: 10.1016/j.lpm.2009.02.024. Epub 2009 May 5.
3
Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
Int Clin Psychopharmacol. 1999 May;14(3):197-8.
4
Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
Int Clin Psychopharmacol. 2015 May;30(3):142-50. doi: 10.1097/YIC.0000000000000064.
5
[Dementia and extrapyramidal problems caused by long-term valproic acid].
Therapie. 2000 Sep-Oct;55(5):629-34.
6
Meige syndrome: double-blind crossover study of sodium valproate.
J Neurol Neurosurg Psychiatry. 1987 Nov;50(11):1522-5. doi: 10.1136/jnnp.50.11.1522.
7
Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Pharmacopsychiatry. 1998 Jul;31(4):122-5. doi: 10.1055/s-2007-979312.
8
[Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
Union Med Can. 1975 Jun;104(6):909-14.
9
Extrapyramidal syndrome and long-acting injectable risperidone.
Am J Psychiatry. 2004 Apr;161(4):756-7. doi: 10.1176/appi.ajp.161.4.756-a.
10
Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
Commun Psychopharmacol. 1977;1(2):157-66.
引用本文的文献
1
Clinical prediction of sodium valproate-induced movement disorders in hospitalized patients: a nomogram-based model using real-world data.
Int J Clin Pharm. 2025 Aug 19. doi: 10.1007/s11096-025-01984-2.
2
Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study.
Front Pharmacol. 2023 Mar 3;14:1077607. doi: 10.3389/fphar.2023.1077607. eCollection 2023.
3
Disabling tremor induced by long-term use of sodium valproate and lamotrigine: Case report.
Medicine (Baltimore). 2017 Nov;96(47):e8711. doi: 10.1097/MD.0000000000008711.
4
Valproate-Associated Parkinsonism: A Critical Review of the Literature.
CNS Drugs. 2016 Jun;30(6):527-40. doi: 10.1007/s40263-016-0341-8.
本文引用的文献
1
The relationship between parkinsonism and tardive dyskinesia.
Am J Psychiatry. 1977 Jul;134(7):781-4. doi: 10.1176/ajp.134.7.781.
2
gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia.
Am J Psychiatry. 1977 Feb;134(2):138-43. doi: 10.1176/ajp.134.2.138.
3
Muscimol: GABA agonist therapy in schizophrenia.
Am J Psychiatry. 1978 Jun;135(6):746-7. doi: 10.1176/ajp.135.6.746.
4
Letter: Bacloffen in schizophrenia.
Lancet. 1976 Jun 5;1(7971):1245. doi: 10.1016/s0140-6736(76)92198-x.
Zotero 插件